[Study of immunological suppression induced by combined use of cyclophosphamide and immunopotentiator, with special reference to its adverse effects].
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D009368:Neoplasm Transplantation; D011509:Proteoglycans / Q000009:adverse effects*; D051381:Rats; D011919:Rats, Inbred Strains; D012517:Sarcoma, Yoshida / Q000276:immunology / Q000473:pathology*
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; C010770:polysaccharide-K; D003520:Cyclophosphamide